医学上无法手术的子宫内膜样腺癌:放疗或激素治疗的模式与结局
本研究基于美国国家癌症数据库(NCDB)2004至2016年数据,纳入1036例医学上无法手术的子宫内膜样腺癌患者,评估放疗(RT)或激素治疗(HT)的模式与疗效。73%患者接受单纯放疗。多因素Cox模型显示HT相比RT总生存更差,但倾向评分加权分析未显示差异;交互作用提示老年和低容量中心患者RT生存更优。
要点
- 医学上无法手术的子宫内膜样腺癌患者中,73%接受单纯放疗。
- 多因素Cox模型显示HT相比RT总生存更差,但倾向评分加权后无差异。
- 老年及低容量中心患者接受RT相比HT生存更优。
核心结论
- 在医学上无法手术的子宫内膜样腺癌患者中,RT相比HT在老年患者和低容量中心治疗的患者中与生存改善相关。
研究设计与样本
- 回顾性队列研究,查询美国国家癌症数据库(NCDB),纳入2004至2016年诊断的医学上无法手术的子宫内膜样腺癌患者1036例,接受RT或HT治疗。
主要发现
- 73%(n=759)患者接受单纯放疗。
- 接受HT相比RT的患者更可能年龄更大、诊断于分析早期年份、在低容量中心治疗、诊断为高级别疾病或位于非都市地区。
- 多因素Cox模型显示HT相比RT与显著更差的总生存相关,但倾向评分加权分析未显示显著差异。
- 交互作用检验显示老年患者和低容量中心患者接受RT相比HT生存改善。
临床怎么用
- 对于医学上无法手术的子宫内膜样腺癌患者,尤其是老年或低容量中心治疗者,可考虑优先选择放疗而非激素治疗。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The optimal treatment for medically inoperable endometrioid endometrial adenocarcinoma is unknown. The goal of this study was to evaluate the patterns of care and efficacy of radiotherapy (RT) or hormone therapy (HT) in the treatment of these patients. METHODS: We performed a query of the National Cancer Database (NCDB) of patients with medically inoperable endometrioid adenocarcinoma of the endometrium diagnosed between 2004 and 2016 and treated with either RT or HT. A multivariate Cox regression model and propensity weighted analyses were used to evaluate overall survival after controlling for confounding variables. A multinomial logistic regression model was used to assess predictors of RT or HT use. RESULTS: A total of 1036 patients were included in this cohort, and 73% (n = 759) were treated with RT alone. Patients who received definitive HT compared to RT were more likely to be older, diagnosed in the earlier years of this analysis, treated at lower-case volume centers, diagnosed with high-grade disease, or located outside of metropolitan areas. On multivariate analysis, treatment with HT alone versus RT alone was associated with significantly worse overall survival in the multivariate Cox model but not on propensity score weighted analysis. Interaction effect testing revealed that older patients and those treated at lower-volume centers had improved survival with RT compared to HT. CONCLUSIONS: We identified factors associated with the receipt of RT or HT in medically inoperable endometrial cancer patients. Treatment with RT correlated with improved survival compared to HT in older patients and those treated at lower-volume centers.
引用
- Reshko LB, Gaskins JT, Rattani A, et al. Patterns of care and outcomes of radiotherapy or hormone therapy in patients with medically inoperable endometrial adenocarcinoma. Gynecol Oncol. 2021. PMID: 34563365. doi:10.1016/j.ygyno.2021.09.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。